Showing results (2621-2630 of 4,839) with videos related to
Sort By:
Pageof 484
Science Translational Medicine|July 20, 2018
Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in miceMaria Maiarù, Charlotte Leese, Michelangelo Certo, et al.Science Translational Medicine|October 20, 2021
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune responseAude De Gassart, Kieu-Suong Le, Patrick Brune, et al.Science Translational Medicine|October 5, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.Science Translational Medicine|October 6, 2021
No one is safe until we are all safeSarah Gilbert, Richard HatchettScience Translational Medicine|October 6, 2021
Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long termLeah C Katzelnick, Jose Victor Zambrana, Douglas Elizondo, et al.Science Translational Medicine|October 13, 2021
Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironmentShuang Wang, Feng Li, Tong Ye, et al.Science Translational Medicine|October 27, 2021
Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G4C2) repeat expansion in vitro and in vivo ALS modelsJessica A Bush, Haruo Aikawa, Rita Fuerst, et al.Science Translational Medicine|May 3, 2022
The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in EnglandRobert S Paton, Christopher E Overton, Thomas WardScience Translational Medicine|May 4, 2022
A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized miceChih-Jen Wei, Wei Bu, Laura A Nguyen, et al.Science Translational Medicine|April 27, 2022
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumorsPaulien Kaptein, Celia Jacoberger-Foissac, Petros Dimitriadis, et al.Pageof 484